Patents by Inventor Suresh Desai
Suresh Desai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11932853Abstract: Provided herein are methods for using RNAi molecules targeting a proteasome beta 5 (PSMB5) gene for controlling Coleopteran insects, methods for producing RNAi molecules targeting PSMB5, and compositions comprising RNAi molecules targeting PSMB5.Type: GrantFiled: September 10, 2021Date of Patent: March 19, 2024Assignee: GreenLight Biosciences, Inc.Inventors: Thais Barros Rodrigues, Suresh Desai, Krishnakumar Sridharan
-
Publication number: 20240086173Abstract: There are provided systems and methods for a distributed autonomous patching system. During patching of a cloud computing architecture, an autonomous patching system may operator autonomously with no to minimal operator input to patch the host machines and corresponding computes of the cloud computing architecture's available applications. This may work by receiving a patch and determining corresponding patching factors for an availability zone of computes in the cloud. The system may then determine a patching topology map having an order of patching nodes for the selected computes of the application in the availability zone. Thereafter, while monitoring those computes, the system may select certain computes into an active processing funnel, where the patch is applied to those computes. Fingerprinting of before and after-patch states may be used to ensure proper patching.Type: ApplicationFiled: September 20, 2023Publication date: March 14, 2024Inventors: Benjamin Thomas, Suresh Mathew, Arvind Sugumar, Krishnakanth Batta, Vaibhav Desai, Ramakrishnan Sumesh Vadassery, Shankar Jothi
-
Publication number: 20230345947Abstract: Disclosed herein are compositions and methods of controlling pests that involves administering RNA interfering agents. Particularly exemplified is the control of Lepidopteran species such as diamondback moths and fall armyworms. Also disclosed is the use of double-stranded RNA molecules to target certain genes in Lepidopteran species.Type: ApplicationFiled: May 13, 2021Publication date: November 2, 2023Inventors: Kenneth E. NARVA, Krishnakumar SRIDHARAN, Upendra Kumar DEVISETTY, Thais BARROS RODRIGUES, Cris OPPERT, Suresh DESAI, Sambit Kumar MISHRA, Evelien VAN EKERT
-
Patent number: 11142768Abstract: Provided herein are methods for using RNAi molecules targeting a proteasome beta 5 (PSMB5) gene for controlling Coleopteran insects, methods for producing RNAi molecules targeting PSMB5, and compositions comprising RNAi molecules targeting PSMB5.Type: GrantFiled: November 8, 2019Date of Patent: October 12, 2021Assignee: GreenLight Biosciences, Inc.Inventors: Thais Barros Rodrigues, Suresh Desai, Krishnakumar Sridharan
-
Publication number: 20200149044Abstract: Provided herein are methods for using RNAi molecules targeting a proteasome beta 5 (PSMB5) gene for controlling Coleopteran insects, methods for producing RNAi molecules targeting PSMB5, and compositions comprising RNAi molecules targeting PSMB5.Type: ApplicationFiled: November 8, 2019Publication date: May 14, 2020Applicant: GreenLight Biosciences, Inc.Inventors: Thais Barros Rodrigues, Suresh Desai, Krishnakumar Sridharan
-
Publication number: 20200093138Abstract: Provided herein are methods for using RNAi molecules targeting an Inhibitor of Apoptosis (IAP) gene for controlling Coleopteran insects, methods for producing RNAi molecules targeting IAP, and compositions comprising RNAi molecules targeting IAP.Type: ApplicationFiled: September 26, 2019Publication date: March 26, 2020Applicant: GreenLight Biosciences, Inc.Inventors: Thais Barros Rodrigues, Suresh Desai, Krishnakumar Sridharan
-
Patent number: 7101683Abstract: The subject invention relates to methods for the simultaneous detection of Hepatitis C Virus (HCV) antigens as well as antibodies produced in response to HCV antigens. Furthermore, the subject invention allows one to detect antigens in the early, acute stage of infection, even prior to the development of antibodies, thereby allowing for early detection of infected blood and blood products, thus improving the safety of the blood supply.Type: GrantFiled: June 26, 2001Date of Patent: September 5, 2006Assignee: Abbott LaboratoriesInventors: Dinesh O. Shah, George J. Dawson, Anthony Scott Muerhoff, Xingli Jiang, Robin A. Gutierrez, Thomas P. Leary, Suresh Desai, James L. Stewart
-
Patent number: 6855809Abstract: The subject invention relates to methods for the simultaneous detection of Hepatitis C Virus (HCV) antigens as well as antibodies produced in response to HCV antigens. Furthermore, the subject invention allows one to detect antigens in the early, acute stage of infection, even prior to the development of antibodies, thereby allowing for early detection of infected blood and blood products, thus improving the safety of the blood supply.Type: GrantFiled: January 7, 2004Date of Patent: February 15, 2005Assignee: Abbott LaboratoriesInventors: Dinesh O. Shah, George J. Dawson, A. Scott Muerhoff, Lily Jiang, Robin A. Gutierrez, Thomas P. Leary, Suresh Desai, James L. Stewart
-
Publication number: 20040185436Abstract: The subject invention relates to methods for the simultaneous detection of Hepatitis C Virus (HCV) antigens as well as antibodies produced in response to HCV antigens. Furthermore, the subject invention allows one to detect antigens in the early, acute stage of infection, even prior to the development of antibodies, thereby allowing for early detection of infected blood and blood products, thus improving the safety of the blood supply.Type: ApplicationFiled: January 7, 2004Publication date: September 23, 2004Inventors: Dinesh O. Shah, George J. Dawson, A. Scott Muerhoff, Lily Jiang, Robin A. Gutierrez, Thomas P. Leary, Suresh Desai, James L. Stewart
-
Patent number: 6777003Abstract: An iodine complex concentrate containing (a) from about 0.5 to about 30% by weight of iodine; (b) from about 0.2 to about 14% by weight of an iodide component selected from the group consisting of iodide salt, iodide acid and mixtures thereof; and (c) from about 2% to about 85% by weight of a nonionic sugar surfactant selected from the group consisting of alkyl glucose esters, aldobionamides, gluconamides, glyceramides, glyceroglycolipids, polygydroxy fatty acid amides, alkyl polyglycosides having the general formula I: R1O(R2O)b(Z)a I wherein R1 is a monovalent organic radical having from about 6 to about 30 carbon atoms; R2 is divalent alkylene radical having from 2 to 4 carbon atoms; Z is a saccharide residue having 5 or 6 carbon atoms; b is a number having a value from 0 to about 12; a is a number having a value from 1 to about 6, and mixtures thereof, all weights being based on the weight of the concentrate.Type: GrantFiled: June 7, 1995Date of Patent: August 17, 2004Assignee: Cognis CorporationInventors: Suresh Desai, John Frederick Hessel
-
Patent number: 6727092Abstract: The subject invention relates to methods for the simultaneous detection of Hepatitis C Virus (HCV) antigens as well as antibodies produced in response to HCV antigens. Furthermore, the subject invention allows one to detect antigens in the early, acute stage of infection, even prior to the development of antibodies, thereby allowing for early detection of infected blood and blood products, thus improving the safety of the blood supply.Type: GrantFiled: June 17, 2002Date of Patent: April 27, 2004Assignee: Abbott LaboratoriesInventors: Dinesh Shah, George Dawson, A. Scott Muerhoff, Thomas P. Leary, Robin A. Guetierrez, Lily Jiang, Suresh Desai, James L. Stewart
-
Publication number: 20030152948Abstract: The subject invention relates to methods for the simultaneous detection of Hepatitis C Virus (HCV) antigens as well as antibodies produced in response to HCV antigens. Furthermore, the subject invention allows one to detect antigens in the early, acute stage of infection, even prior to the development of antibodies, thereby allowing for early detection of infected blood and blood products, thus improving the safety of the blood supply.Type: ApplicationFiled: June 17, 2002Publication date: August 14, 2003Inventors: Dinesh O. Shah, George J. Dawson, A. Scott Muerhoff, Lily Jiang, Robin A. Gutierrez, Thomas P. Leary, Suresh Desai, James L. Stewart
-
Publication number: 20030108858Abstract: The subject invention relates to methods for the simultaneous detection of Hepatitis C Virus (HCV) antigens as well as antibodies produced in response to HCV antigens. Furthermore, the subject invention allows one to detect antigens in the early, acute stage of infection, even prior to the development of antibodies, thereby allowing for early detection of infected blood and blood products, thus improving the safety of the blood supply.Type: ApplicationFiled: June 26, 2001Publication date: June 12, 2003Inventors: Dinesh O. Shah, George A. Dawson, A. Scott Muerhoff, Lily Jiang, Robin A. Gutierrez, Thomas P. Leary, Suresh Desai, James L. Stewart
-
Patent number: 6395472Abstract: The present invention relates to nucleic oligomer primers or probes useful for detection of TTV in test samples. Also provided are assays which utilize these primers and probes, as well as test kits which contain these oligomer primers and/or probes. In addition, the present invention encompasses the use of TTV nucleotide sequences as nucleic acid vectors and as markers for determining transmission between individuals as well as the route thereof. Additionally, the present invention encompasses a method of detecting TTV infection prior to xenotransplatation of a tissue or organ.Type: GrantFiled: February 5, 1999Date of Patent: May 28, 2002Assignee: Abbott LaboratoriesInventors: Thomas P. Leary, James Erker, Michelle Chalmers, John Simons, Larry Birkenmeyer, Scott Muerhoff, Tami Pilot-Matias, Suresh Desai, Isa Mushahwar